Safety of 5α-Reductase Inhibitors and Spironolactone in Breast Cancer Patients Receiving Endocrine Therapies

    November 2018 in “ Breast Cancer Research and Treatment ”
    Raquel Rozner, Azael Freites-Martínez, Jerry Shapiro … Mario E. Lacouture
    Studysummary In this review, researchers found no evidence of interactions between 5α-reductase inhibitors or spironolactone and endocrine therapies for breast cancer, with no consistent changes in estrogen levels or increased breast cancer risk associated with spironolactone usage.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on europepmc.org →
    Discuss this study in the Community →

    Research cited in this study 76

    1. Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer JAMA Dermatology · 2018
    2. Clinical Efficacy of Oral Administration of Finasteride at a Dose of 2.5 mg/Day in Women with Female Pattern Hair Loss Dermatologic Therapy · 2018
    3. Finasteride Treatment and Male Breast Cancer: A Register-Based Cohort Study in Four Nordic Countries Cancer Medicine · 2017
    4. Permanent Alopecia in Patients with Breast Cancer After Taxane Chemotherapy and Adjuvant Hormonal Therapy: Clinicopathologic Findings in a Cohort of 10 Patients Journal of The American Academy of Dermatology · 2017
    5. Interventions for Female Pattern Hair Loss JAMA Dermatology · 2017
    6. Side Effects Related to 5 Alpha-Reductase Inhibitor Treatment of Hair Loss in Women: A Review PubMed · 2016
    7. Long-Term Use of 5α-Reductase Inhibitors and the Risk of Male Breast Cancer Cancer Causes & Control · 2014
    8. Minoxidil May Suppress Androgen Receptor-Related Functions Oncotarget · 2014
    9. Permanent Chemotherapy-Induced Alopecia in Early Breast Cancer Patients After (Neo)Adjuvant Chemotherapy: Long-Term Follow-Up Cancer Research · 2013
    10. Aromatase Inhibitor Therapy and Hair Loss Among Breast Cancer Survivors Breast Cancer Research and Treatment · 2013
    11. Alopecia With Endocrine Therapies in Patients With Cancer Oncologist · 2013
    12. Improved Efficacy of Low-Dose Spironolactone and Metformin Combination Than Either Drug Alone in the Management of Women With Polycystic Ovary Syndrome: A Six-Month, Open-Label Randomized Study The Journal of Clinical Endocrinology and Metabolism · 2013
    13. The Efficacy and Safety of 5α-Reductase Inhibitors in Androgenetic Alopecia: A Network Meta-Analysis and Benefit–Risk Assessment of Finasteride and Dutasteride Journal of Dermatological Treatment · 2013
    14. Aromatase Inhibitors Induce Male Pattern Hair Loss in Women Annals of Oncology · 2013
    15. Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride The Journal of Urology · 2013
    16. Hair: What Is New in Diagnosis and Management? Dermatologic Clinics · 2012
    17. Finasteride in the Treatment of Female Pattern (Androgenic) Alopecia: A Case Report and Review of the Literature PubMed · 2012
    18. Permanent Scalp Alopecia Related to Breast Cancer Chemotherapy by Sequential Fluorouracil/Epirubicin/Cyclophosphamide (FEC) and Docetaxel: A Prospective Study of 20 Patients Annals of Oncology · 2012
    19. Hormonal Changes in Menopause: Do They Contribute to a Midlife Hair Crisis in Women? British Journal of Dermatology · 2011
    20. Role of Genetics and Sex Steroid Hormones in Male Androgenetic Alopecia and Female Pattern Hair Loss: An Update Australasian Journal of Dermatology · 2011
    21. Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia Archives of Dermatology · 2010
    22. Female Pattern Hair Loss: Beyond an Androgenic Aetiology? British Journal of Dermatology · 2010
    23. 5 mg/Day Finasteride Treatment for Normoandrogenic Asian Women with Female Pattern Hair Loss Journal of The European Academy of Dermatology and Venereology · 2010
    24. Innovative Use of Spironolactone as an Antiandrogen in the Treatment of Female Pattern Hair Loss PubMed · 2010
    25. Finasteride Treatment for One Year in 35 Hirsute Patients Experimental and Clinical Endocrinology & Diabetes · 2009
    26. Gene-Wide Association Study Between the Aromatase Gene (CYP19A1) and Female Pattern Hair Loss British Journal of Dermatology · 2009
    27. Hair Loss in Women: Comprehensive Overview and Treatment Options Seminars in Cutaneous Medicine and Surgery · 2009
    28. The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride Journal of The American Academy of Dermatology · 2006
    29. The Hair Follicle as an Estrogen Target and Source Endocrine Reviews · 2006
    30. Finasteride Treatment of Female Pattern Hair Loss Archives of Dermatology · 2006
    31. Substantial Sex-Dependent Differences in the Response of Human Scalp Hair Follicles to Estrogen Stimulation In Vitro Advocate Gender-Tailored Management of Female Versus Male Pattern Balding Journal of Investigative Dermatology Symposium Proceedings · 2005
    32. Treatment of Female Pattern Hair Loss With Oral Antiandrogens British Journal of Dermatology · 2005
    33. Intermittent Low-Dose Finasteride Is as Effective as Daily Administration for the Treatment of Hirsute Women Fertility and Sterility · 2004
    34. Finasteride Versus Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism International journal of gynaecology and obstetrics · 2004
    35. A Comparison Between Spironolactone and Spironolactone Plus Finasteride in the Treatment of Hirsutism European journal of endocrinology · 2004
    36. Finasteride Treatment of Patterned Hair Loss in Normoandrogenic Postmenopausal Women Dermatology · 2004
    37. Use of Cyproterone Acetate, Finasteride, and Spironolactone to Treat Idiopathic Hirsutism Fertility and Sterility · 2003
    38. Low-Dose (2.5 mg/Day) Finasteride Treatment in Hirsutism Gynecological Endocrinology · 2003
    39. The Benefits of Finasteride for Hirsute Women with Polycystic Ovary Syndrome or Idiopathic Hirsutism Gynecological Endocrinology · 2003
    40. Hair Loss in Women with Hyperandrogenism: Four Cases Responding to Finasteride Journal of The American Academy of Dermatology · 2002
    41. Comparison of High-Dose Finasteride (5 mg/day) Versus Low-Dose Finasteride (2.5 mg/day) in the Treatment of Hirsutism European journal of endocrinology · 2002
    42. Role of Androgens in Female-Pattern Androgenetic Alopecia, Either Alone or Associated with Other Symptoms of Hyperandrogenism Archives of Dermatological Research · 2000
    43. Lack of Efficacy of Finasteride in Postmenopausal Women with Androgenetic Alopecia Journal of The American Academy of Dermatology · 2000
    44. A Prospective, Randomized Trial Comparing Flutamide (250 mg/d) and Finasteride (5 mg/d) in the Treatment of Hirsutism Fertility and Sterility · 2000
    45. Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double-Blind, Placebo-Controlled Trial The Journal of Clinical Endocrinology and Metabolism · 2000
    46. A Comparative Study of a Gonadotropin-Releasing Hormone Agonist and Finasteride on Idiopathic Hirsutism PubMed · 2000
    47. The Effects of Finasteride on Scalp Skin and Serum Androgen Levels in Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1999
    48. Comparison of Finasteride Versus Flutamide in the Treatment of Hirsutism European journal of endocrinology · 1999
    49. Treatment of Hair Loss The New England Journal of Medicine · 1999
    50. A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism The Journal of Clinical Endocrinology and Metabolism · 1999
    51. Treatment of Hirsutism: Comparisons Between Different Antiandrogens with Central and Peripheral Effects Fertility and sterility · 1999
    52. Effect of Finasteride in Idiopathic Hirsutism Journal of Endocrinological Investigation · 1998
    53. Comparison of Cyproterone Acetate Plus Ethinyl Estradiol and Finasteride in the Treatment of Hirsutism Journal of Endocrinological Investigation · 1998
    54. Comparison of Finasteride Versus Spironolactone in the Treatment of Idiopathic Hirsutism Fertility and Sterility · 1997
    55. Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia Journal of Investigative Dermatology · 1997
    56. Finasteride in the Treatment of Hirsutism Obstetrical & Gynecological Survey · 1996
    57. Outcome of Long-Term Treatment with the 5α-Reductase Inhibitor Finasteride in Idiopathic Hirsutism: Clinical and Hormonal Effects During a 1-Year Course of Therapy and 1-Year Follow-Up Fertility and Sterility · 1996
    58. Androgen Metabolism as It Affects Hair Growth in Androgenetic Alopecia Dermatologic Clinics · 1996
    59. Finasteride in the Treatment of Hirsutism: New Therapeutic Perspectives Fertility and Sterility · 1996
    60. A Randomized Trial of Minoxidil in Chemotherapy-Induced Alopecia Journal of The American Academy of Dermatology · 1996
    61. Clinical and Endocrine Effects of Finasteride, a 5α-Reductase Inhibitor, in Women with Idiopathic Hirsutism Fertility and Sterility · 1995
    62. A Prospective Randomized Trial Comparing Finasteride to Spironolactone in the Treatment of Hirsute Women The Journal of Clinical Endocrinology and Metabolism · 1995
    63. Clinical and Hormonal Effects of the 5 Alpha-Reductase Inhibitor Finasteride in Idiopathic Hirsutism The Journal of Clinical Endocrinology and Metabolism · 1994
    64. Minoxidil as a Prophylaxis of Doxorubicin-Induced Alopecia Annals of Oncology · 1994
    65. Effects of Finasteride, a 5 Alpha-Reductase Inhibitor, on Circulating Androgens and Gonadotropin Secretion in Hirsute Women The Journal of Clinical Endocrinology and Metabolism · 1994
    66. Minoxidil Stimulates Mouse Vibrissae Follicles in Organ Culture Journal of Investigative Dermatology · 1989
    67. Action of Topical Minoxidil in the Bald Stump-Tailed Macaque Journal of The American Academy of Dermatology · 1987
    68. The Effect of Spironolactone on Hirsutism and Female Androgen Metabolism Clinical endocrinology · 1985
    69. The Effects of Two Doses of Spironolactone on Serum Androgens and Anagen Hair in Hirsute Women Fertility and sterility · 1985
    70. Oral Spironolactone Therapy for Female Patients with Acne, Hirsutism, or Androgenic Alopecia British Journal of Dermatology · 1985
    71. Treatment of Hirsutism With Spironolactone JAMA · 1982
    72. A Novel Use of Spironolactone: Treatment of Hirsutism ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 1980
    73. New Therapeutic Approach to the Hirsute Patient Fertility and sterility · 1979
    74. Spironolactone Therapy for Hirsutism in a Hyperandrogenic Woman Annals of internal medicine · 1978
    75. Testosterone Metabolism in the Skin Archives of dermatology · 1975
    76. Testosterone Metabolism in the Skin: A Review of Its Function in Androgenetic Alopecia, Acne Vulgaris, and Idiopathic Hirsutism Including Recent Studies with Antiandrogens Archives of Dermatology · 1975

    Related research 2

    1. Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study Dermatology · 2017
    2. Lack of Effect of Spironolactone on Hair Shaft Diameter in Hirsute Females Postgraduate medical journal · 1989